Correlation Between Subjective and Objective Severity of Oral and Ocular Dryness in Primary Sjögren Syndrome

REFERENCES

1. 1.↵
   1. Patel R,
   2. Shahane A.

   The epidemiology of Sjögren’s syndrome. Clin Epidemiol 2014;6:247-55.

   OpenUrl
2. 2.↵
   1. Ienopoli S,
   2. Carsons SE.

   Extraglandular manifestations of primary Sjögren’s syndrome. Oral Maxillofac Surg Clin North Am 2014;26:91-9.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Begley CG,
   2. Chalmers RL,
   3. Abetz L,
   4. Venkataraman K,
   5. Mertzanis P,
   6. Caffery BA, et al.

   The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci 2003;44:4753-61.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Kotsis K,
   2. Voulgari PV,
   3. Tsifetaki N,
   4. Drosos AA,
   5. Carvalho AF,
   6. Hyphantis T.

   Illness perceptions and psychological distress associated with physical health-related quality of life in primary Sjögren’s syndrome compared to systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int 2014;34:1671-81.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Al-Ezzi MY,
   2. Pathak N,
   3. Tappuni AR,
   4. Khan KS.

   Primary Sjögren’s syndrome impact on smell, taste, sexuality and quality of life in female patients: a systematic review and meta-analysis. Mod Rheumatol 2017;27:623-9.

   OpenUrl
6. 6.↵
   1. Liu Z,
   2. Dong Z,
   3. Liang X,
   4. Liu J,
   5. Xuan L,
   6. Wang J, et al.

   Health-related quality of life and psychological status of women with primary Sjögren’s syndrome: a cross-sectional study of 304 Chinese patients. Medicine 2017;96:e9208.

   OpenUrl
7. 7.↵
   1. Lackner A,
   2. Ficjan A,
   3. Stradner MH,
   4. Hermann J,
   5. Unger J,
   6. Stamm T, et al.

   It’s more than dryness and fatigue: the patient perspective on health-related quality of life in primary Sjögren’s syndrome – a qualitative study. PLoS One 2017;12:e0172056.

   OpenUrl
8. 8.↵
   1. Kassan SS,
   2. Moutsopoulos HM.

   Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004; 164:1275-84.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Vitali C,
   2. Bombardieri S,
   3. Jonsson R,
   4. Moutsopoulos HM,
   5. Alexander EL,
   6. Carsons SE, et al; European Study Group on Classification Criteria for Sjögren’s Syndrome

   . Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Shiboski CH,
    2. Shiboski SC,
    3. Seror R,
    4. Criswell LA,
    5. Labetoulle M,
    6. Lietman TM, et al; International Sjögren’s Syndrome Criteria Working Group

    . 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017;69:35-45.

    OpenUrl
11. 11.↵
    1. Douglas L.

    Facilitating timely diagnosis of Sjögren’s Syndrome. BDJ Team 2018;5:18026.

    OpenUrl
12. 12.↵
    1. Beckman KA,
    2. Luchs J,
    3. Milner MS.

    Making the diagnosis of Sjögren’s syndrome in patients with dry eye. Clin Ophthalmol 2016; 10:43-53.

    OpenUrl
13. 13.↵
    1. Akpek, EK,
    2. Bunya VY,
    3. Saldanha IJ.

    Sjögren’s syndrome: more than just dry eye. Cornea 2019;38:658-61.

    OpenUrl
14. 14.↵
    1. Nichols KK,
    2. Nichols JJ,
    3. Mitchell GL.

    The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004;23:762-70.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Adatia FA,
    2. Michaeli-Cohen A,
    3. Naor J,
    4. Caffery B,
    5. Bookman A,
    6. Slomovic A.

    Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjögren’s syndrome. Can J Ophthalmol 2004; 39:767-71.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Bunya VY,
    2. Langelier N,
    3. Chen S,
    4. Pistilli M,
    5. Vivino FB,
    6. Massaro-Giordano G.

    Tear osmolarity in Sjögren syndrome. Cornea 2013;32:922-7.

    OpenUrl
17. 17.↵
    1. Cho MA,
    2. Ko JY,
    3. Kim YK,
    4. Kho HS.

    Salivary flow rate and clinical characteristics of patients with xerostomia according to its aetiology. J Oral Rehabil 2010;37:185-93.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Zeev MS,
    2. Miller DD,
    3. Latkany R.

    Diagnosis of dry eye disease and emerging technologies. Clin Ophthalmol 2014; 8:581-90.

    OpenUrl
19. 19.↵
    1. Farsi NM.

    Signs of oral dryness in relation to salivary flow rate, pH, buffering capacity and dry mouth complaints. BMC Oral Health 2007;7:15.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Hijjaw O,
    2. Alawneh M,
    3. Ojjoh K,
    4. Abuasbeh H,
    5. Alkilany A,
    6. Qasem N, et al.

    Correlation between Xerostomia Index, Clinical Oral Dryness Scale, and ESSPRI with different hyposalivation tests. Open Access Rheumatol 2019;11:11-8.

    OpenUrl
21. 21.↵
    1. Brun JG,
    2. Jacobsen H,
    3. Kloster R,
    4. Cuida M,
    5. Johannesen AC,
    6. Høyeraal HM, et al.

    Use of a sicca symptoms questionnaire for the identification of patients with Sjögren’s syndrome in a heterogeneous hospital population with various rheumatic diseases. Clin Exp Rheumatol 1994;12:649-52.

    OpenUrlPubMed
22. 22.↵
    1. Duret PM,
    2. Meyer N,
    3. Saraux A,
    4. Devauchelle-Pensec V,
    5. Seror R,
    6. Le-Guern V, et al.

    Seasonal effect on fatigue, pain and dryness in primary Sjögren’s syndrome. Arthritis Res Ther 2020;22:39.

    OpenUrl
23. 23.
    1. Cornec D,
    2. Devauchelle-Pensec V,
    3. Mariette X,
    4. Jousse-Joulin S,
    5. Berthelot JM,
    6. Perdriger A, et al.

    Development of the Sjögren’s Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy. Rheumatology 2015; 54:1699-708.

    OpenUrlCrossRefPubMed
24. 24.
    1. Bowman SJ,
    2. Everett CC,
    3. O’Dwyer JL,
    4. Emery P,
    5. Pitzalis C,
    6. Ng WF, et al.

    Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjögren’s syndrome. Arthritis Rheumatol 2017; 69:1440-50.

    OpenUrl
25. 25.
    1. Forsblad-d’Elia H,
    2. Carlsten H,
    3. Labrie F,
    4. Konttinen YT,
    5. Ohlsson C.

    Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren’s syndrome; supplementation with dehydroepiandrosterone restores the concentrations. J Clin Endocrinol Metab 2009;94:2044-51.

    OpenUrlCrossRefPubMed
26. 26.
    1. Hartkamp A,
    2. Geenen R,
    3. Godaert GL,
    4. Bootsma H,
    5. Kruize AA,
    6. Bijlsma JW, et al.

    Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren Syndrome: a randomised controlled trial. Ann Rheum Dis 2008;67:91-7.

    OpenUrlAbstract/FREE Full Text
27. 27.
    1. Lee J,
    2. Koh JH,
    3. Kwok SK,
    4. Park SH.

    The EULAR Sjögren’s Syndrome Patient-Reported Index is an independent determinant of health-related utility values of Korean patients with primary Sjögren’s syndrome. Clin Exp Rheumatol 2016;34:663-7.

    OpenUrl
28. 28.
    1. Segal BM,
    2. Pogatchnik B,
    3. Henn L,
    4. Rudser K,
    5. Sivils KM.

    Pain severity and neuropathic pain symptoms in primary Sjogren’s syndrome: a comparison study of seropositive and seronegative Sjogren’s syndrome. Arthritis Care Res 2013;65:1291-8.

    OpenUrlCrossRef
29. 29.↵
    1. Shi H,
    2. Zheng LY,
    3. Zhang P,
    4. Yu CQ.

    miR-146a and miR-155 expression in PBMCs from patients with Sjögren’s syndrome. J Oral Pathol Med 2014;43:792-7.

    OpenUrl
30. 30.↵
    1. Wang MTM,
    2. Thomson WM,
    3. Craig JP.

    Association between symptoms of xerostomia and dry eye in older people. Cont Lens Anterior Eye 2020;43:99-102.

    OpenUrl
31. 31.↵
    1. Mcmonnies CW.

    The potential role of neuropathic mechanisms in dry eye syndromes. J Optom 2017;10:5-13.

    OpenUrl
32. 32.↵
    1. Akpek EK,
    2. Mathews P,
    3. Hahn S,
    4. Hessen M,
    5. Kim J,
    6. Grader-Beck T, et al.

    Ocular and systemic morbidity in a longitudinal cohort of Sjögren’s syndrome. Ophthalmology 2015;122;56-61.
33. 33.↵
    1. Bookman AA,
    2. Shen H,
    3. Cook RJ,
    4. Bailey D,
    5. McComb RJ,
    6. Rutka JA, et al.

    Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjögren’s syndrome but not patients with sicca. Arthritis Rheum 2011;63:2014-20.

    OpenUrlCrossRefPubMed